Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borson, S.
Right arrow Articles by Raskind, M. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Borson, S.
Right arrow Articles by Raskind, M. A.
NEUROLOGY 1997;48:17S-24S
© 1997 American Academy of Neurology

Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease

Soo Borson, MD and Murray A. Raskind, MD

From the Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuroscience (Dr. Borson), University of Washington Hospital; Department of Psychiatry (Dr. Raskind), Veterans Affairs Puget Sound Health Care System; and the University of Washington Alzheimer's Disease Research Center (Drs. Borson and Raskind), Seattle, WA.
Supported in part by grants from the National Institutes on Aging, Alzheimer's Disease Research Center (S.B. and M.R.), and the Alzheimer's Association (S.B.).
Address correspondence and reprint requests to Dr. Soo Borson, Geriatric Psychiatry, University of Washington Medical Center, Box 356560, 1959 NE Pacific St., Seattle, WA 98195-6560.

Abstract.

Article abstract-Behavioral symptoms are an integral component of Alzheimer's disease (AD) and an important cause of failure of home care. Well-chosen pharmacologic and psychosocial treatments can improve many of the distressing problem behaviors that occur in the course of the disease and, in some cases, may delay institutionalization. However, controlled trials remain scarce, and prediction of treatment outcome for individual patients is still uncertain at best. Recent improvements in the characterization of behavioral syndromes in AD hold promise for increasing the specificity of treatment choice and the predictability of response. This article reviews features of the major behavioral problems associated with AD and evidence for the effectiveness of existing treatments. We argue that the origins of behavioral disturbances include both intrinsic neurobiological aspects of the disease and environmental provocations, and present an approach to treatment decision-making that respects both the clinician's need to intervene to reduce suffering and the limitations of current knowledge.

NEUROLOGY 1997;48(Suppl 6): S17-S24






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by AAN Enterprises, Inc.